Dark

Check out our Level2View

DMTK
DermTech, Inc. Common Stock
stock NASDAQ

Inactive

Jun 26, 2024

0.0940USD-11.321%(-0.0120)3,662,379

Pre-market

0.00USD-100.000%(-0.11)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 31, 2022

04:01PM EST DermTech Management to Participate in Upcoming Investor Conferences Business Wire

Jan 7, 2022

01:07PM EST Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 Benzinga

01:01PM EST Stephens & Co. Initiates Coverage On DermTech with Overweight Rating Benzinga

Dec 15, 2021

12:25PM EST BioIQ, DermTech Report Deal To Bring Increased Patient Access To Precision Genomics Benzinga

12:24PM EST BioIQ and DermTech Enter into an Agreement to Add Non-invasive DermTech PR Newswire

Nov 29, 2021

04:30PM EST DermTech Unveils DermTech Stratum, an Expanded Translational Medicine Service Offering for Non-invasive Biomarker Analysis Business Wire

Nov 18, 2021

04:30PM EST DermTech Presents Precision Approaches to Personalized Dermatology at 2021 Dermatology Drug Development Summit Business Wire

Nov 10, 2021

08:23AM EST The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance Benzinga

Nov 9, 2021

04:38PM EST DermTech Q3 EPS $(0.68) Misses $(0.64) Estimate, Sales $3.03M Miss $3.41M Estimate Benzinga

04:01PM EST DermTech Reports Third Quarter 2021 Financial Results Business Wire

12:08PM EST DermTech's Return On Capital Employed Overview Benzinga

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

11:14AM EST DermTech Partners With DermatologistOnCall To Make Its DermTech Melanoma Test Available Through DermatologistOnCall Telemedicine Platform Benzinga

Nov 8, 2021

04:50PM EST DermTech and DermatologistOnCall Enter Agreement to Improve Access to the DermTech Melanoma Test with Noninvasive, At-Home Sample Collection Business Wire

Nov 2, 2021

04:01PM EDT DermTech Management to Participate in Upcoming Investor Conferences Business Wire

Oct 26, 2021

04:01PM EDT DermTech to Announce Third Quarter Financial Results on November 9, 2021 Business Wire

Oct 11, 2021

04:30PM EDT DermTech Presents in Expert Panel at Inaugural Alliance for Innovation in Integrated Healthcare Summit Business Wire

Oct 4, 2021

04:01PM EDT DermTech Announces New Appointment of L'Oral USA Leader Nathalie Gerschtein Keraudy to its Board of Directors Business Wire

Sep 8, 2021

04:01PM EDT DermTech Management to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit Business Wire

Aug 31, 2021

04:01PM EDT DermTech Management to Participate at the Lake Street 2021 BIG5 Conference Business Wire

Aug 20, 2021

02:37PM EDT Looking into DermTech's Return on Capital Employed Benzinga

Aug 4, 2021

05:03PM EDT Recap: DermTech Q2 Earnings Benzinga

04:34PM EDT DermTech Q2 EPS $(0.59) Misses $(0.53) Estimate, Sales $3.12M Beat $2.85M Estimate Benzinga

04:01PM EDT DermTech Reports Second Quarter 2021 Financial Results Business Wire

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

04:10AM EDT Earnings Scheduled For August 4, 2021 Benzinga

Aug 1, 2021

11:19AM EDT The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs Benzinga

Jul 21, 2021

04:30PM EDT DermTech to Announce Second Quarter Financial Results on August 4, 2021 Business Wire

04:05PM EDT DermTech Announces New San Diego Headquarters Business Wire

Jul 13, 2021

08:14AM EDT Cramer Weighs In On FireEye, 3D Systems, More Benzinga

Jul 6, 2021

08:05AM EDT DermTech Appoints Monica Tellado To Board RTTNews

08:00AM EDT DermTech Announces New Appointment of Monica Tellado to its Board of Directors Business Wire

Jun 24, 2021

05:00PM EDT DermTech CEO John Dobak, M.D. Wins San Diego Business Journal CEO of the Year Award, Public Company, Medium Category Business Wire

Jun 22, 2021

04:31PM EDT DermaTech Reports Partnership With University Of Barcelona For Research Study On Atopic Dermatitis, Psoriasis, No Terms Disclosed Benzinga

04:30PM EDT DermTech to Partner with University of Barcelona for Research Study on Atopic Dermatitis and Psoriasis Business Wire

Jun 17, 2021

08:33AM EDT The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme Benzinga

Jun 16, 2021

04:01PM EDT DermTech Announces Three New Key Leadership Appointments: Chief Medical Officer, Vice President, Sales and Vice President, Information Technology and Digital Systems Business Wire

Jun 4, 2021

07:30AM EDT Humacyte to Provide Investor Update on June 7 GlobeNewswire Inc

Jun 2, 2021

04:30PM EDT DermTech Announces Three New Scientific Advisory Board Members Business Wire

May 26, 2021

07:30AM EDT Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced that the company has received a 2021 Life Sciences Award from the Triangle Business Journal. GlobeNewswire Inc

May 18, 2021

04:01PM EDT DermTech Management to Participate in Upcoming Investor Conferences Business Wire

May 13, 2021

04:51PM EDT Recap: DermTech Q1 Earnings Benzinga

04:36PM EDT DermTech Q1 EPS $(0.55) Misses $(0.42) Estimate, Sales $2.52M Beat $2.11M Estimate Benzinga

04:01PM EDT DermTech Reports First Quarter 2021 Financial Results Business Wire

08:10AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use Benzinga

04:15AM EDT Earnings Scheduled For May 13, 2021 Benzinga

May 11, 2021

04:01PM EDT DermTech Management to Present at the UBS Global Healthcare Virtual Conference Business Wire

May 10, 2021

04:30PM EDT DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit Business Wire

May 3, 2021

04:30PM EDT DermTech Pledges up to $1 Million to Raise Awareness and Support Accessibility of Skin Exams Business Wire

02:59PM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2021 Benzinga

09:30AM EDT BTIG Initiates Coverage On DermTech with Buy Rating, Announces Price Target of $53 Benzinga

Apr 29, 2021

04:01PM EDT DermTech to Announce First Quarter Financial Results on May 13, 2021 Business Wire

Apr 28, 2021

07:26AM EDT The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping Benzinga

Apr 27, 2021

04:43PM EDT DermTech to Collaborate on Longitudinal Study on Hidradenitis Suppurativa Benzinga

04:30PM EDT DermTech to Collaborate on Longitudinal Study on Hidradenitis Suppurativa (HS) Business Wire

Apr 22, 2021

04:32PM EDT DermTech Says Introduces PLAplus With Improved Sensitivity For Early Detection Of Melanoma Benzinga

04:30PM EDT DermTech Introduces PLAplus with Improved Sensitivity for Early Detection of Melanoma Business Wire

Apr 19, 2021

04:30PM EDT DermTech Joins Skin Cancer Foundation Corporate Council Business Wire

Apr 15, 2021

04:01PM EDT OptumInsight Study Describes Cost Savings of DermTech's Pigmented Lesion Assay in the Management of Melanoma Business Wire

Mar 4, 2021

04:04PM EST DermTech Sees Q1 Assay Revenue $1.6M-$1.9M Benzinga

04:03PM EST DermTech Q4 EPS $(0.48) Beats $(0.55) Estimate, Sales $2.10M Beat $1.78M Estimate Benzinga

04:01PM EST DermTech Reports Fourth Quarter and Full Year 2020 Financial Results Business Wire

08:12AM EST The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company Benzinga

04:07AM EST Earnings Scheduled For March 4, 2021 Benzinga

Feb 27, 2021

09:04PM EST The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings Benzinga

Feb 23, 2021

07:25AM EST The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts Benzinga

Feb 22, 2021

04:30PM EST DermTech Abstracts Selected to Present at Society of Investigative Dermatology Virtual Meeting Business Wire

Feb 18, 2021

04:01PM EST DermTech to Announce Fourth Quarter 2020 Financial Results on March 4, 2021 Business Wire

Feb 17, 2021

04:01PM EST DermTech Management to Participate in Upcoming Investor Conferences Business Wire

07:27AM EST The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal Benzinga

Feb 11, 2021

11:21AM EST Stocks That Hit 52-Week Highs On Thursday Benzinga

Feb 10, 2021

04:01PM EST DermTech Enters Into Agreement with Blue Cross Blue Shield of Texas Business Wire

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

Feb 8, 2021

04:30PM EST DermTech Announces New Scientific Advisory Board Members Business Wire

Feb 5, 2021

07:44AM EST The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street Benzinga

Feb 3, 2021

04:01PM EST DermTech Management to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference Business Wire

Jan 28, 2021

04:36PM EST DermTech Featured in Melanoma Research Foundation Weekly "Ask the Expert" Facebook Live Events Alongside Notable Industry Scientists Business Wire

Jan 27, 2021

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

Jan 26, 2021

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 22, 2021

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 22, 2021 Benzinga

05:58AM EST Oppenheimer Initiates Coverage On DermTech with Outperform Rating, Announces Price Target of $53 Benzinga

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 19, 2021

04:31PM EST DermTech Chief Scientific Officer Michael Howell Presented at Dermatology Summit 2021 Business Wire

Jan 16, 2021

02:22PM EST Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 14, 2021

04:33PM EST DermTech Highlights Publication Of Results Of Findings Regarding DermTech's Pigmented Lesion Assay In SKIN Benzinga

04:30PM EST DermTech Pigmented Lesion Assay (PLA) to Enrich Melanoma Positivity Nearly Five-Fold in Biopsied Lesions: Findings from a Large US Registry Business Wire

07:57AM EST The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates Benzinga

Jan 13, 2021

07:25AM EST The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations Benzinga

Jan 12, 2021

05:40PM EST Matrix Service Company (MTRX) - Shares of the company jumped 35% in extended trading session on Tuesday. Chart Industries, Inc. (GTLS), a manufacturer of engineered equipment, signed a Memorandum of Understanding with Matrix Service for the development of standardized hydrogen solutions in North America. RTTNews

04:03PM EST DermTech Announces Inclusion Of Non-Invasive Genomic Patch Testing In The National Comprehensive Cancer Network Cutaneous Melanoma Guidelines Benzinga

04:01PM EST DermTech Announces Inclusion of Non-Invasive Genomic Patch Testing in the National Comprehensive Cancer Network(r) (NCCN) Cutaneous Melanoma Guidelines Business Wire

Jan 11, 2021

04:01PM EST DermTech Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares Business Wire

Jan 8, 2021

07:25AM EST The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga

Jan 7, 2021

12:06AM EST DermTech Announces Pricing Of Public Offering Of4.34 Mln Shares Of Common Stock At $29.5/Shr RTTNews

12:00AM EST DermTech Announces Pricing of Public Offering of Common Stock Business Wire

Jan 6, 2021

04:07PM EST DermTech Announces Proposed Public Offering Of Common Stock RTTNews

04:03PM EST DermTech Announces A Common Stock Offering; No Size Disclosed Benzinga

04:01PM EST DermTech Announces Proposed Public Offering of Common Stock Business Wire

Jan 5, 2021

04:30PM EST DermTech Announces Appointment of General Counsel Business Wire

Dec 30, 2020

08:16AM EST The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data Benzinga

Dec 29, 2020

05:05PM EST DermTech Receives Positive Medical Coverage by Geisinger Health System Business Wire

Dec 28, 2020

04:01PM EST DermTech Management to Present at the ICR Conference 2021 Business Wire

Dec 17, 2020

04:31PM EST DermTech Reports Topline Results From TRUST Study: Confirm 'High Negative Predictive Value of the PLA at 99% and Find No Significant Adverse Outcomes After Long-Term Follow-Up of PLA Negative Tests' Benzinga

04:30PM EST DermTech Announces Topline Results of its TRUST Study: Results Confirm the High Negative Predictive Value of the PLA at 99% and Find No Significant Adverse Outcomes After Long-Term Follow-Up of PLA Negative Tests Business Wire

Dec 11, 2020

09:01AM EST DermTech Announces Inclusion Of Its Melanoma Test In Two Continuing Medical Education Sessions At 2020 Fall Clinical Virtual Grand Rounds And Mount Sinai Winter Symposium Benzinga

09:00AM EST DermTech's Melanoma Test Included in Two Continuing Medical Education ("CME") Sessions at 2020 Fall Clinical Virtual Grand Rounds and Mount Sinai Winter Symposium Business Wire

Dec 10, 2020

04:01PM EST DermTech Reports Deal With Blue Shield Of California Benzinga

04:01PM EST DermTech Enters Into Agreement With Blue Shield of California Business Wire

Dec 3, 2020

04:30PM EST DermTech Presents Updates in Precision Medicine at 2020 Dermatology Drug Development Summit Business Wire

Nov 20, 2020

08:08AM EST DermTech Enters Deal With Blue Cross Blue Shield Of Illinois RTTNews

08:05AM EST DermTech Enters Agreement With Blue Cross Blue Shield Of Illinois Benzinga

Nov 17, 2020

04:31PM EST DermTech Presents New Clinical Research Abstract At The 2020 Fall Clinical Dermatology Conference Benzinga

Nov 10, 2020

04:02PM EST DermTech Q3 EPS $(0.50) Beats $(0.55) Estimate Benzinga

04:01PM EST DermTech Reports Third Quarter 2020 Financial Results Business Wire

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

Nov 4, 2020

04:01PM EST DermTech to Participate in Upcoming Investor Conferences Business Wire

Oct 30, 2020

10:06AM EDT Benzinga's Top Upgrades, Downgrades For October 30, 2020 Benzinga

06:22AM EDT William Blair Initiates Coverage On DermTech with Outperform Rating Benzinga

Oct 27, 2020

04:01PM EDT DermTech to Announce Third Quarter 2020 Financial Results on November 10, 2020 Business Wire

Sep 10, 2020

09:31AM EDT Benzinga's Top Upgrades, Downgrades For September 10, 2020 Benzinga

06:51AM EDT Cowen & Co. Initiates Coverage On DermTech with Outperform Rating, Announces Price Target of $20 Benzinga

Sep 8, 2020

04:18PM EDT DermTech S-3 Shows Registration For 87.79K Share Common Stock Offering Benzinga

08:33AM EDT DermTech Announces Appointment Of Chief Scientific Officer Benzinga

Sep 3, 2020

04:01PM EDT DermTech to Participate in Upcoming Investor Conferences Business Wire

Aug 5, 2020

04:11PM EDT DermTech Q2 EPS $(0.58) Up From $(0.84) YoY, Sales $844.00K Up From $614.00K YoY Benzinga

04:01PM EDT DermTech, Inc. Reports Second Quarter 2020 Financial Results and Provides Corporate Update Business Wire

Share